HAVCR1 and prostate carcinoma: In regard to decreased entry into the circulation as HAVcR-1 is expressed in prostate glandular epithelial cells, it would be expected that, similarly to PSA, the disruption of the normal prostate architecture that occurs with prostate cancer progression would cause increased entry into the circulation [19].